| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Annals of Thoracic Surgery, Vol 48, 536-539, Copyright © 1989 by The Society of Thoracic Surgeons
F Alajmo, G Calamai, AM Perna, G Melissano, P Pretelli, MF Palmarini, F Carbonetto, D Noferi, V Boddi and A Palminiello
Two groups of patients were prospectively studied to evaluate the
hemostatic effects of high-dose aprotinin in open heart operations. Group A
patients (n = 22) received aprotinin during the entire surgical procedure.
Group B patients (n = 12) served as controls. The groups were homogeneous
for base variables and for cardiopulmonary bypass duration. Postoperative
bleeding was lower in group A (mean, 486 mL) than in group B (830 mL) (p
less than 0.01). The need for banked blood decreased by approximately half
in the aprotinin patients (mean: group A, 213 mL; group B, 409 mL).
Hemoglobin levels were similar in the two groups (postoperative day 7:
group A, 11.29 g/100 mL; group B, 11.26 g/100 mL; NS). Platelet count
decreased at the end of operation in both groups (99,000 and 95,000/mL,
respectively; NS) and then increased beyond baseline levels before
discharge. No complications were observed that could be attributed to
aprotinin. In conclusion, we believe that the use of high-dose aprotinin is
safe and effective. It decreases blood loss and reduces the need for banked
blood in cardiac operations, particularly in select groups of patients (eg,
those undergoing reoperation, Jehovah's Witnesses, those with renal
failure).
ARTICLES
High-dose aprotinin: hemostatic effects in open heart operations
Department of Cardiothoracic Surgery, University of Florence, Italy.
This article has been cited by other articles:
|
|
 |
|
  M. D. McEvoy, S. T. Reeves, J. G. Reves, and F. G. Spinale Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action Anesth. Analg., October 1, 2007; 105(4): 949 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Brown, N. J.O. Birkmeyer, and G. T. O'Connor Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery Circulation, June 5, 2007; 115(22): 2801 - 2813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Chong, C. R. Hampton, and E. D. Verrier Microvascular Inflammatory Response in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 333 - 354. [Abstract] [PDF]
|
|
|
|
 |
|
 S. V Moran, G. Lema, J. Medel, M. J Irarrazaval, R. Zalaquett, B. Garayar, and R. Flaskamp Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery Perfusion, March 1, 2000; 15(2): 105 - 110. [Abstract] [PDF]
|
|
|
|
|
|
J. J. Munoz, N. J. O. Birkmeyer, J. D. Birkmeyer, G. T. O'Connor, and L. J. Dacey Is {epsilon}-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery? : A Meta-Analysis Circulation, January 12, 1999; 99(1): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Westaby Aprotinin Fifteen Years Later Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 366 - 375. [Abstract] [PDF]
|
|
|
|
|
|
S. Cicek, U. Demirkilic, E. Kuralay, E. Ozal, and H. Tatar Postoperative Aprotinin: Effect on Blood Loss and Transfusion Requirements in Cardiac Operations Ann. Thorac. Surg., May 1, 1996; 61(5): 1372 - 1376. [Abstract] [Full Text]
|
|
|
|
|
|
I. Rodrigus, K. Vermeyen, S. De Hert, B. Amsel, and P. Walter Efficacy and safety of aprotinin in aortocoronary bypass and valve replacement operations: a placebo-controlled randomized double-blind study Perfusion, January 1, 1996; 11(4): 313 - 318. [Abstract] [PDF]
|
|
|
|
 |
|
 H. P. Wendel, W. Heller, J. Michel, G. Mayer, C. Ochsenfahrt, U. Graeter, J. Schulze, H.-M. Hoffmeister, and H.-E. Hoffmeister Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1164 - 1172. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Rousou, R. M. Engelman, J. E. Flack III, D. W. Deaton, and S. G. Owen Tranexamic Acid Significantly Reduces Blood Loss Associated With Coronary Revascularization Ann. Thorac. Surg., March 1, 1995; 59(3): 671 - 675. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Shainoff, F. G. Estafanous, J.-P. Yared, P. M. DiBello, K. Kottke-Marchant, and F. D. Loop Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., September 1, 1994; 108(3): 437 - 445. [Abstract] [Full Text]
|
|
|
|
|
|
F. Herynkopf, F. Lucchese, E. Pereira, R. Kalil, P. Prates, and I. A. Nesralla Aprotinin in children undergoing correction of congenital heart defectsA double-blind pilot study J. Thorac. Cardiovasc. Surg., September 1, 1994; 108(3): 517 - 521. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Santoli, D. G. Di Mattia, P. Castelli, A. Condemi, S. Guzzetti, P. Meraviglia, and C. Santoli Reduction of Homologous Transfusions in Open-Heart Surgery Vascular and Endovascular Surgery, November 1, 1992; 26(9): 693 - 699. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
